Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$3.95 - $5.41 $134,695 - $184,481
-34,100 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$4.37 - $9.46 $3,059 - $6,622
-700 Reduced 2.01%
34,100 $240,000
Q3 2020

Nov 05, 2020

SELL
$8.56 - $26.93 $21,297 - $67,001
-2,488 Reduced 6.67%
34,800 $315,000
Q2 2020

Aug 12, 2020

SELL
$21.21 - $31.55 $238,676 - $355,032
-11,253 Reduced 23.18%
37,288 $1.03 Million
Q1 2020

May 12, 2020

SELL
$18.43 - $38.04 $33,174 - $68,472
-1,800 Reduced 3.58%
48,541 $1.07 Million
Q4 2019

Jan 27, 2020

BUY
$29.6 - $43.71 $201,280 - $297,228
6,800 Added 15.62%
50,341 $1.9 Million
Q3 2019

Oct 31, 2019

BUY
$29.87 - $42.22 $1.09 Million - $1.55 Million
36,620 Added 529.11%
43,541 $1.34 Million
Q2 2019

Aug 15, 2019

BUY
$31.16 - $39.46 $215,658 - $273,102
6,921 New
6,921 $273,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.